Anlon Healthcare Limited (NSEI: AHCL)
Health Care · Pharmaceuticals · IN
Rs28.11
-14.46% today · +122.0% 1Y
Anlon Healthcare Limited (NSEI: AHCL) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $154.38M.
Over the last twelve months the share price has gained 122.0%, trading between 10.37 and 37.24.
Tweenvest scores Anlon Healthcare Limited across four factors: quality 65/100, value 35/100, growth 100/100. Its strongest factor is growth.
AHCL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $154.38M
- Revenue (TTM)
- $23.93M
- P/E
- 37.01
- EPS
- 0.76
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- Rs37.24
- 52-week low
- Rs10.37
- Avg volume (3M)
- —
- Shares outstanding
- 531.51M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| TerrAscend Corp.TSX: TSND | $157.10M | CA$0.73 | -3.33% |
| AGP LimitedKASE: AGP | $156.49M | PKRs155.48 | +2.42% |
| Cenra Inc.TWSE: 3716 | $155.60M | NT$34.15 | +0.74% |
| Societe de Promotion Pharmaceutique du Maghreb S.A.CBSE: PRO | $155.42M | MAD— | — |
| Jagsonpal Pharmaceuticals LimitedNSEI: JAGSNPHARM | $153.68M | Rs225.60 | -2.65% |
| Fermenta Biotech LimitedBSE: 506414 | $153.31M | Rs517.50 | -6.14% |
| Mayne Pharma Group LimitedASX: MYX | $152.01M | AU$2.66 | -6.67% |
| Amrutanjan Health Care LimitedBSE: 590006 | $151.84M | Rs508.30 | -1.07% |
Figures last refreshed Oct 11, 2026.